This view is incorrect because hepatitis B virus infected people can be divided into four stages: i. Immune tolerance stage, when most of the two pairs of half performance HBeAg positive, and the values of HBsAg, HBeAg, HBVDNA are high, liver function is basically normal, clinically there are no symptoms. Medically, these people are called hepatitis B virus carriers and do not need antiviral treatment. Second, the immune clearance period, liver function is abnormal, and some symptoms related to liver disease will appear clinically. At this time, we can diagnose a person with chronic hepatitis B, and need to choose an appropriate antiviral treatment plan. Third, the immune control period, this period of patients are characterized by basically normal liver function, high HBsAg values, but the values of HBeAg and HBVDNA can be to the extent of undetectable, these patients do not need treatment, but should be observed, characterized by the situation about liver tumors. Fourth, the immune escape period, the patient’s virus in this period and re-positive, whether to be treated according to liver function, liver damage and a series of comprehensive considerations before deciding.